AMLN Amylin Pharmaceuticals, Inc. (MM)

SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the Oppenheimer Diabetes Conference on Wednesday, September 7, 2005 at 9:35 a.m. ET in New York, at the Thomas Weisel Healthcare Tailwinds Conference on Thursday, September 8, 2005 at 9:45 a.m. ET in Boston and at the BioCentury Newsmakers Conference on Friday, September 9, 2005 at 10:00 a.m. ET in New York. Dennis Kim, Senior Director, Medical Affairs of Amylin Pharmaceuticals, will be presenting at Oppenheimer. Ginger Graham, President and Chief Executive Officer of Amylin Pharmaceuticals, will be presenting at Thomas Weisel and BioCentury Newsmakers. The live presentations will be webcast, and recordings will be made available following the events. The breakout session at BioCentury will also be webcast live, and a recording will be made available following the session. The webcasts and recordings will be accessible through Amylin's corporate website, located at http://www.amylin.com/. To access the live webcasts, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive Director, Investor Relations of Amylin Pharmaceuticals, Inc., +1-858-552-2200, ext. 727 Web site: http://www.amylin.com/

Copyright